RACA Journal September 2020 | Page 42

Getting Technical CHARLES NICOLSON Charles Nicolson has a physics and chemistry degree from Natal University which he subsequently put to good use by applying speciality chemicals in mining and industrial processes where water is a major factor. This created an enduring interest in water technology, a passion that expanded to the HVAC industry in 1984 when he joined BHT Water Treatment. Since then, water technology in HVAC water circuits has continued to be an abiding interest. THE ORIGIN OF COVID-19 – WHERE DID IT COME FROM? By Charles Nicolson The previous article published in the August issue of RACA referred to the recently discovered Corona D-19 virus which has dominated headlines worldwide since the end of January this year when it began to spread out from China causing epidemic levels of infections in many countries. Coronaviruses are, in fact, a large family of viruses which are the cause of respiratory infections ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). FDA ida gov Figure 2: Human Immunodeficiency Virus (HIV) FDA ida gov (a) (b) Figure 1: Images of two types of Corona viruses. Covid-19 is image (a) Another widespread corona-type viral disease is AIDS (acquired immune deficiency syndrome) which often develops relatively soon after infections by HIV (human immunodeficiency virus) although it may remain dormant within a human body and only become active after many years. In common with almost all diseases caused by viruses, there is not yet a cure, as such, for AIDS. However, treatment programmes with suitable vaccines can substantially reduce the progress of the disease and also prevent subsequent complications from developing. Now that the newest coronavirus disease, referred to as Covid-19, has become a world-wide addition to all the other coronavirus type infections, it is expected that the primary countermeasures against attacks by Covid-19 will continue to depend on keeping new infections as low as possible until an effective and safe vaccine has been developed and put into production. At the time of writing, progress in both testing and manufacturing various types of vaccines is reportedly advancing at unprecedented rates due to world-wide international collaboration and cooperation which includes China, the UK and the US. There are currently ten experimental vaccines undergoing field trials and several more types are expected to become available for trials after initial laboratory testing has been completed. However, vaccines are essentially defensive agents which interfere with the mechanisms by which viruses enter and react with animal and human cells. Vaccines will help to limit total numbers of Covid-19 by preventing transmission and spreading 40 RACA Journal I September 2020 www.hvacronline.co.za